Sarepta Therapeutics, Inc. (SRPT)
22.33
+0.33
(+1.50%)
USD |
NASDAQ |
Dec 24, 12:59
22.30
-0.02
(-0.11%)
After-Hours: 13:59
Sarepta Therapeutics SG&A Expense (TTM): 527.29M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Pfizer Inc. | 13.91B |
| Arrowhead Pharmaceuticals, Inc. | 123.94M |
| Amgen, Inc. | 6.976B |
| Bristol Myers Squibb Co. | 7.222B |
| Alnylam Pharmaceuticals, Inc. | 1.181B |